Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ruzicka

Showing results (171-180 of 564) with videos related to

Pageof 57
Sort By:
Experimental Dermatology|February 1, 1994
Cytokine system as potential target for antipsoriatic therapyL Kemény, G Michel, A Dobozy, et al.
Clinical and Experimental Dermatology|December 11, 2002
Type 1 segmental cutaneous leiomyomatosisK Lang, J Reifenberger, T Ruzicka, et al.
Journal of the American Academy of Dermatology|July 21, 2001
Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agentM Megahed, S Schmiedeberg, J Becker, et al.
Clinical and Experimental Dermatology|June 20, 2013
Treatment of Darier disease with oral alitretinoinV Letulé, T Herzinger, T Ruzicka, et al.
Deutsche Medizinische Wochenschrift (1946)|March 1, 2012
[Friend or Foe?--Psoriasin and Koebnerisin: multifunctional defence molecules in skin differentiation, tumorigenesis and inflammation]S Zwicker, D Bureik, T Ruzicka, et al.
Lancet (London, England)|January 6, 1996
High-dose UVA1 for urticaria pigmentosaH Stege, E Schöpf, T Ruzicka, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2010
Dead Sea climatotherapy for vitiligo: a retrospective study of 436 patientsT Czarnowicki, M Harari, T Ruzicka, et al.
Archives of Dermatological Research|January 1, 1991
12-Hydroxyeicosatetraenoic acid (12-HETE) is a chemotactic stimulus for epidermal cellsR Hein, E Gross, T Ruzicka, et al.
The British Journal of Dermatology|December 3, 1999
Effect of topical tazarotene in the treatment of congenital ichthyosesB Hofmann, H Stege, T Ruzicka, et al.
Immunology Today|March 1, 1996
FK506 in the treatment of inflammatory skin disease: promises and perspectivesG Michel, L Kemeny, B Homey, et al.
Pageof 57

Showing results (171-180 of 564) with videos related to

Sort By:
Pageof 57
Experimental Dermatology|February 1, 1994
Cytokine system as potential target for antipsoriatic therapyL Kemény, G Michel, A Dobozy, et al.
Clinical and Experimental Dermatology|December 11, 2002
Type 1 segmental cutaneous leiomyomatosisK Lang, J Reifenberger, T Ruzicka, et al.
Journal of the American Academy of Dermatology|July 21, 2001
Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agentM Megahed, S Schmiedeberg, J Becker, et al.
Clinical and Experimental Dermatology|June 20, 2013
Treatment of Darier disease with oral alitretinoinV Letulé, T Herzinger, T Ruzicka, et al.
Deutsche Medizinische Wochenschrift (1946)|March 1, 2012
[Friend or Foe?--Psoriasin and Koebnerisin: multifunctional defence molecules in skin differentiation, tumorigenesis and inflammation]S Zwicker, D Bureik, T Ruzicka, et al.
Lancet (London, England)|January 6, 1996
High-dose UVA1 for urticaria pigmentosaH Stege, E Schöpf, T Ruzicka, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2010
Dead Sea climatotherapy for vitiligo: a retrospective study of 436 patientsT Czarnowicki, M Harari, T Ruzicka, et al.
Archives of Dermatological Research|January 1, 1991
12-Hydroxyeicosatetraenoic acid (12-HETE) is a chemotactic stimulus for epidermal cellsR Hein, E Gross, T Ruzicka, et al.
The British Journal of Dermatology|December 3, 1999
Effect of topical tazarotene in the treatment of congenital ichthyosesB Hofmann, H Stege, T Ruzicka, et al.
Immunology Today|March 1, 1996
FK506 in the treatment of inflammatory skin disease: promises and perspectivesG Michel, L Kemeny, B Homey, et al.
Pageof 57